Sotera Health Company SHC
18.34
(0.11)
(0.60%)
as of 25 Sep
- Market cap
- $5.3B
- P/E
- 32.1×
Follow SHC
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
10.85% | 15.42% | 22.73% | 27.78% | |
| 1.75% | 2.46% | 3.72% | 5.01% | ||
ROIC |
8.64% | 9.07% | 9.38% | 9.82% | |
Return on Tangible Assets |
3.87% | 5.22% | 7.74% | 10.33% | |
Average Days of Receivables |
49.04 | 46.21 | 44.07 | 47.61 | |
Free Cash Flow per Share |
0.30 | 0.53 | 0.34 | 0.39 | |
Free Cash Flow |
86.62 | 149.18 | 96.84 | 112.70 | |
Capital Expenditures |
(153.19) | (138.02) | (164.27) | (179.49) | |
Piotroski F-Score |
6.00 | 7.00 | 8.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
7.76% | 9.01% | 8.24% | 8.98% | |
Accounts Receivable Turnover |
7.70 | 7.91 | 8.59 | 7.93 | |
Accounts Payable Turnover |
7.66 | 7.79 | 7.25 | 6.65 | |
Inventory Turnover |
9.78 | 10.01 | 8.98 | 9.42 | |
Average Days of Payables |
44.25 | 54.93 | 52.62 | 67.33 | |
Days of Inventory on Hand |
35.94 | 38.31 | 39.45 | 37.57 | |
Tax Rate |
(0.55) | (0.47) | (0.43) | (0.38) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
22.35% | 21.72% | 21.69% | 21.15% | |
Share Based Compensation of Revenue |
2.73% | 2.65% | 3.20% | 3.05% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.33 | 3.68 | 2.22 | 1.79 | |
Depreciation/Fixed assets |
0.14 | 0.13 | 0.12 | 0.11 | |
Capex/Depreciation |
(1.02) | (0.97) | (1.24) | (1.37) | |
Revenue per Share |
4.05 | 4.10 | 4.17 | 4.26 | |
Operating CF per Share |
0.84 | 1.01 | 0.92 | 1.02 | |
Capex per Share |
(0.54) | (0.49) | (0.58) | (0.63) | |
Capex to Sales |
0.13 | 0.12 | 0.14 | 0.15 | |
Net Profit Margin |
4.81% | 6.70% | 9.91% | 13.44% |
Columns are period end dates